This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Commercial packaging and clinical trial services specialist Packaging Coordinators, Inc. (PCI) is pleased to announce the introduction of refrigerated GMP packaging facilities for temperature controlled pharmaceuticals at its facilities in the UK.
It is widely recognized that more and more temperature sensitive investigational drug product has limited stability data available and as such there is an increasing need for projects to be labelled and packed within a refrigerated environment to maintain the drugs' efficacy.
PCI is focussed on the rapidly changing needs of the Clinical Trial industry and responding to increased customer demand for specialized temperature controlled packaging and has introduced a dedicated capability for packaging at its site in Hay-on-Wye.
The safety of our customers' product is of upmost importance to us stated Tim Roberts, Associate Director of Clinical Services. By introducing this additional service, we will not only be able to ensure the safety and integrity of our customers' products, we will help make significant efficiencies to their packaging lead times of temperature sensitive material.
PCI has invested significantly in supporting Cold Chain logistics for packaging both investigational as well as commercial medicinal products in a variety of drug delivery forms, including oral solids and parenteral delivery forms such as injectable and transdermal. PCI's global network of 14 locations features designated sites with specialized capabilities such as Cold Chain packaging, in addition to significant on-site Cold Chain storage at -8C, -20C, -40C and -80C. PCI also supports controlled temperature shipments to worldwide investigational sites through its logistics network, which includes the recently announced construction of a new Storage and Distribution site for investigational medicines in North America slated to open in August of this year.
